MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors

Mafalda Rizzuti, Giuseppe Filosa, Valentina Melzi, Luca Calandriello, Laura Dioni, Valentina Bollati, Nereo Bresolin, Giacomo Pietro Comi, Silvia Barabino, Monica Nizzardo, Stefania Corti

Research output: Contribution to journalArticle

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder that is characterized by a progressive degeneration of motor neurons (MNs). The pathomechanism underlying the disease is largely unknown, even though increasing evidence suggests that RNA metabolism, including microRNAs (miRNAs) may play an important role. In this study, human ALS induced pluripotent stem cells were differentiated into MN progenitors and their miRNA expression profiles were compared to those of healthy control cells. We identified 15 downregulated miRNAs in patients' cells. Gene ontology and molecular pathway enrichment analysis indicated that the predicted target genes of the differentially expressed miRNAs were involved in neurodegeneration-related pathways. Among the 15 examined miRNAs, miR-34a and miR504 appeared particularly relevant due to their involvement in the p53 pathway, synaptic vesicle regulation and general involvement in neurodegenerative diseases. Taken together our results demonstrate that the neurodegenerative phenotype in ALS can be associated with a dysregulation of miRNAs involved in the control of disease-relevant genetic pathways, suggesting that targeting entire gene networks can be a potential strategy to treat complex diseases such as ALS.

Original languageEnglish
Article number10105
JournalScientific Reports
Volume8
Issue number1
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Amyotrophic Lateral Sclerosis
Motor Neurons
MicroRNAs
Down-Regulation
Induced Pluripotent Stem Cells
Inborn Genetic Diseases
Gene Ontology
Synaptic Vesicles
Gene Regulatory Networks
Nervous System Diseases
Neurodegenerative Diseases
RNA
Phenotype
Genes

ASJC Scopus subject areas

  • General

Cite this

MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. / Rizzuti, Mafalda; Filosa, Giuseppe; Melzi, Valentina; Calandriello, Luca; Dioni, Laura; Bollati, Valentina; Bresolin, Nereo; Comi, Giacomo Pietro; Barabino, Silvia; Nizzardo, Monica; Corti, Stefania.

In: Scientific Reports, Vol. 8, No. 1, 10105, 01.12.2018.

Research output: Contribution to journalArticle

Rizzuti, Mafalda ; Filosa, Giuseppe ; Melzi, Valentina ; Calandriello, Luca ; Dioni, Laura ; Bollati, Valentina ; Bresolin, Nereo ; Comi, Giacomo Pietro ; Barabino, Silvia ; Nizzardo, Monica ; Corti, Stefania. / MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. In: Scientific Reports. 2018 ; Vol. 8, No. 1.
@article{1003b6d91ee74103bd61e432da43f73f,
title = "MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors",
abstract = "Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder that is characterized by a progressive degeneration of motor neurons (MNs). The pathomechanism underlying the disease is largely unknown, even though increasing evidence suggests that RNA metabolism, including microRNAs (miRNAs) may play an important role. In this study, human ALS induced pluripotent stem cells were differentiated into MN progenitors and their miRNA expression profiles were compared to those of healthy control cells. We identified 15 downregulated miRNAs in patients' cells. Gene ontology and molecular pathway enrichment analysis indicated that the predicted target genes of the differentially expressed miRNAs were involved in neurodegeneration-related pathways. Among the 15 examined miRNAs, miR-34a and miR504 appeared particularly relevant due to their involvement in the p53 pathway, synaptic vesicle regulation and general involvement in neurodegenerative diseases. Taken together our results demonstrate that the neurodegenerative phenotype in ALS can be associated with a dysregulation of miRNAs involved in the control of disease-relevant genetic pathways, suggesting that targeting entire gene networks can be a potential strategy to treat complex diseases such as ALS.",
author = "Mafalda Rizzuti and Giuseppe Filosa and Valentina Melzi and Luca Calandriello and Laura Dioni and Valentina Bollati and Nereo Bresolin and Comi, {Giacomo Pietro} and Silvia Barabino and Monica Nizzardo and Stefania Corti",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-28366-1",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors

AU - Rizzuti, Mafalda

AU - Filosa, Giuseppe

AU - Melzi, Valentina

AU - Calandriello, Luca

AU - Dioni, Laura

AU - Bollati, Valentina

AU - Bresolin, Nereo

AU - Comi, Giacomo Pietro

AU - Barabino, Silvia

AU - Nizzardo, Monica

AU - Corti, Stefania

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder that is characterized by a progressive degeneration of motor neurons (MNs). The pathomechanism underlying the disease is largely unknown, even though increasing evidence suggests that RNA metabolism, including microRNAs (miRNAs) may play an important role. In this study, human ALS induced pluripotent stem cells were differentiated into MN progenitors and their miRNA expression profiles were compared to those of healthy control cells. We identified 15 downregulated miRNAs in patients' cells. Gene ontology and molecular pathway enrichment analysis indicated that the predicted target genes of the differentially expressed miRNAs were involved in neurodegeneration-related pathways. Among the 15 examined miRNAs, miR-34a and miR504 appeared particularly relevant due to their involvement in the p53 pathway, synaptic vesicle regulation and general involvement in neurodegenerative diseases. Taken together our results demonstrate that the neurodegenerative phenotype in ALS can be associated with a dysregulation of miRNAs involved in the control of disease-relevant genetic pathways, suggesting that targeting entire gene networks can be a potential strategy to treat complex diseases such as ALS.

AB - Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder that is characterized by a progressive degeneration of motor neurons (MNs). The pathomechanism underlying the disease is largely unknown, even though increasing evidence suggests that RNA metabolism, including microRNAs (miRNAs) may play an important role. In this study, human ALS induced pluripotent stem cells were differentiated into MN progenitors and their miRNA expression profiles were compared to those of healthy control cells. We identified 15 downregulated miRNAs in patients' cells. Gene ontology and molecular pathway enrichment analysis indicated that the predicted target genes of the differentially expressed miRNAs were involved in neurodegeneration-related pathways. Among the 15 examined miRNAs, miR-34a and miR504 appeared particularly relevant due to their involvement in the p53 pathway, synaptic vesicle regulation and general involvement in neurodegenerative diseases. Taken together our results demonstrate that the neurodegenerative phenotype in ALS can be associated with a dysregulation of miRNAs involved in the control of disease-relevant genetic pathways, suggesting that targeting entire gene networks can be a potential strategy to treat complex diseases such as ALS.

UR - http://www.scopus.com/inward/record.url?scp=85049665390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049665390&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-28366-1

DO - 10.1038/s41598-018-28366-1

M3 - Article

AN - SCOPUS:85049665390

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 10105

ER -